# A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.

Source: https://onco.cc/trials/nct07559929/  
OnCo record `nct07559929` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of toripalimab, carboplatin and cisplatin in lung cancer, run by Hangzhou DAC Biotechnology Co., Ltd., now recruiting.

## Summary

A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer. is a phase 1/2, interventional study registered as NCT07559929 by Hangzhou DAC Biotechnology Co., Ltd., with a registry enrolment figure of 200 participants, started 2026-08-19 and due to reach its primary completion in 2028-06-01. Interventions recorded: DXC006; Toripalimab; Carboplatin; Cisplatin. Conditions listed: Small Cell Lung Cancer. Primary outcome: Progression Free Survival (PFS); 6-month progression-free survival rate; Recommended Phase 2 Dose (RP2D). Lung eligibility wording from the registry: "Histologically or cytologically confirmed small cell lung cancer (SCLC)". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07559929
- Phase: 1/2
- Setting: A Phase Ib/II Study to Evaluate the Safety and Efficacy of DXC006 for Injection Combined With Immune Checkpoint Inhibitors or Platinum-Based Agents in Patients With Small Cell Lung Cancer.
- Sponsor: Hangzhou DAC Biotechnology Co., Ltd.
- Enrolled: 200

## Sources

- ClinicalTrials.gov NCT07559929: https://clinicaltrials.gov/study/NCT07559929

## Connected records

- cancers: [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Toripalimab](https://onco.cc/drugs/toripalimab/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07559929.json